LFST · NASDAQ
LifeStance Health Group (LFST) Stock Price & Fundamentals
LifeStance Health Group (LFST) closed at $462.89 on Oct 9, 2026, down 0.54% from the previous close of $465.41.
Share price, past year
1Y +16.87%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $462.89 |
| Sep 30, 2026 | $458.49 |
| Aug 31, 2026 | $470.75 |
| Jul 31, 2026 | $446.71 |
| Jun 30, 2026 | $456.96 |
| May 29, 2026 | $434.78 |
| Apr 30, 2026 | $438.12 |
| Mar 31, 2026 | $430.20 |
| Feb 27, 2026 | $428.55 |
| Jan 30, 2026 | $427.93 |
| Dec 31, 2025 | $397.34 |
| Nov 28, 2025 | $401.45 |
| Oct 31, 2025 | $404.38 |
Key statistics
- Market cap
- $176.83B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $1.58B
- Net income (TTM)
- $50.60M
- Shares outstanding
- 382M
- Dividend yield
- —
- 52-week range
- $390.76 – $485.39
LifeStance Health Group's market cap is $176.83B, based on a share price of $462.89 and 382M shares outstanding as of Jun 30, 2026.
Financials
LifeStance Health Group reported revenue of $1.42B for fiscal 2025, up 13.85% from fiscal 2024.
LifeStance Health Group earned net income of $9.66M in fiscal 2025, a net margin of 0.7%.
Fiscal 2025 revenue was the highest in the 6 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.42B | +13.9% | $9.66M | 0.7% | — | $110.03M |
| FY2024ended Dec 31, 2024 | $1.25B | +18.5% | −$57.44M | −4.6% | — | $85.69M |
| FY2023ended Dec 31, 2023 | $1.06B | +22.8% | −$186.26M | −17.6% | — | −$57.40M |
| FY2022ended Dec 31, 2022 | $859.54M | +59,383.9% | −$215.56M | −25.1% | — | −$26.47M |
| FY2021ended Dec 31, 2021 | $1.45M | −99.3% | −$307.20M | −21,259.3% | — | −$85.07M |
| FY2019ended Dec 31, 2019 | $212.52M | — | $5.67M | 2.7% | — | $2.73M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $435.35M | $23.61M | — |
| Q1 FY2026ended Mar 31, 2026 | $403.48M | $14.24M | — |
| Q4 FY2025ended Dec 31, 2025 | $382.20M | $11.67M | — |
| Q3 FY2025ended Sep 30, 2025 | $363.81M | $1.08M | — |
| Q2 FY2025ended Jun 30, 2025 | $345.31M | −$3.79M | — |
| Q1 FY2025ended Mar 31, 2025 | $332.97M | $709.00K | — |
| Q4 FY2024ended Dec 31, 2024 | $325.48M | −$13.78M | — |
| Q3 FY2024ended Sep 30, 2024 | $312.72M | $709.00K | — |
Company profile
- Name
- LifeStance Health Group, Inc.
- Ticker
- LFST
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Health Services
- Headquarters
- 4800 N. Scottsdale Road, Suite 2500, Scottsdale, AZ 85251
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001845257
Recent SEC filings
- Sep 11, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 7, 2026
- Jun 4, 2026
- May 12, 2026
- May 7, 2026
- May 7, 2026
Frequently asked questions
What is LifeStance Health Group's stock price?
LifeStance Health Group (LFST) closed at $462.89 on Oct 9, 2026, down 0.54% from the previous close of $465.41.
What is LifeStance Health Group's market cap?
LifeStance Health Group's market cap is $176.83B, based on a share price of $462.89 and 382M shares outstanding as of Jun 30, 2026.
How much revenue does LifeStance Health Group make?
LifeStance Health Group reported revenue of $1.42B for fiscal 2025, up 13.85% from fiscal 2024.
Does LifeStance Health Group pay a dividend?
LifeStance Health Group's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from LifeStance Health Group, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures